Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003474923 | SCV004203199 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2D | 2022-10-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003474923 | SCV004298282 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2D | 2024-05-06 | criteria provided, single submitter | clinical testing | This sequence change results in a frameshift in the SGCA gene (p.Asp328Alafs*90). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 60 amino acid(s) of the SGCA protein and extend the protein by 29 additional amino acid residues. This variant is not present in population databases (gnomAD no frequency). This frameshift has been observed in individual(s) with clinical features of limb girdle muscular dystrophy (PMID: 27671536; Invitae; external communication). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as c.608_609insCG. ClinVar contains an entry for this variant (Variation ID: 191294). For these reasons, this variant has been classified as Pathogenic. |
Genomic Medicine Center of Excellence, |
RCV003474923 | SCV004808262 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2D | 2024-03-29 | criteria provided, single submitter | clinical testing | |
Genomic Medicine Center of Excellence, |
RCV000171485 | SCV000221684 | likely pathogenic | not provided | flagged submission | research |